90 related articles for article (PubMed ID: 3066168)
1. Molecular implications of Ph (+) myelodysplastic syndrome.
Toyama K; Ohyashiki K; Ohyashiki JH
Adv Exp Med Biol; 1988; 241():67-71. PubMed ID: 3066168
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome with Philadelphia-like chromosome without bcr rearrangement.
Ohyashiki JH; Ohyashiki K; Fujieda H; Iwabuchi H; Enomoto Y; Watanabe Y; Toyama K
Cancer Genet Cytogenet; 1988 Oct; 35(2):151-8. PubMed ID: 3180018
[TBL] [Abstract][Full Text] [Related]
3. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
[TBL] [Abstract][Full Text] [Related]
6. Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia.
Verschraegen CF; Talpaz M; Hirsch-Ginsberg CF; Pherwani R; Rios MB; Stass SA; Kantarjian HM
Blood; 1995 May; 85(10):2705-10. PubMed ID: 7742530
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Report of two cases and review of the literature.
Verhoef G; Meeus P; Stul M; Mecucci C; Cassiman JJ; Van Den Berghe H; Boogaerts M
Cancer Genet Cytogenet; 1992 Apr; 59(2):161-6. PubMed ID: 1581881
[TBL] [Abstract][Full Text] [Related]
8. Acute leukaemia in bcr/abl transgenic mice.
Heisterkamp N; Jenster G; ten Hoeve J; Zovich D; Pattengale PK; Groffen J
Nature; 1990 Mar; 344(6263):251-3. PubMed ID: 2179728
[TBL] [Abstract][Full Text] [Related]
9. Essential thrombocythemia with the Philadelphia chromosome and BCR-ABL gene rearrangement. An entity distinct from chronic myeloid leukemia and Philadelphia chromosome-negative essential thrombocythemia.
LeBrun DP; Pinkerton PH; Sheridan BL; Chen-Lai J; Dubé ID; Poldre PA
Cancer Genet Cytogenet; 1991 Jul; 54(1):21-5. PubMed ID: 2065312
[TBL] [Abstract][Full Text] [Related]
10. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
[TBL] [Abstract][Full Text] [Related]
11. Molecular differentiation of two different translocations producing two apparent Ph chromosomes in a patient with CML.
Gonsebatt ME; Lisker R; Mutchinick O; Ruz L; Cortez J; Labardini J; Schraven KD; Pearce-Birge L
Cancer Genet Cytogenet; 1991 Jul; 54(2):247-52. PubMed ID: 1884359
[TBL] [Abstract][Full Text] [Related]
12. Triple Philadelphia chromosomes with major-bcr rearrangement in hypotriploid erythroleukaemia.
Yamamoto K; Nakamura Y; Arai H; Saito K; Furusawa S
Eur J Haematol; 2000 Sep; 65(3):182-7. PubMed ID: 11007054
[TBL] [Abstract][Full Text] [Related]
13. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
Xue YQ
Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
[TBL] [Abstract][Full Text] [Related]
14. Studies of BCR and ABL gene rearrangements in chronic myelogenous leukemia patients by conventional and pulsed-field gel electrophoresis using gel inserts.
Jiang XY; Trujillo JM; Dao D; Liang JC
Cancer Genet Cytogenet; 1989 Oct; 42(2):287-94. PubMed ID: 2676142
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of variant translocations in chronic myelogenous leukemia.
Verma RS; Macera MJ; Benn P; Groffen J
Oncogene; 1989 Sep; 4(9):1145-8. PubMed ID: 2674857
[TBL] [Abstract][Full Text] [Related]
16. Standpoint on imprinting of BCR and ABL.
Fioretos T; Heisterkamp N; Groffen J
Leukemia; 1995 Apr; 9(4):743-4. PubMed ID: 7723414
[TBL] [Abstract][Full Text] [Related]
17. A new chromosomal breakpoint in Ph positive, bcr negative chronic myelogenous leukemia. Report of a case.
Negrini M; Tallarico A; Pazzi I; Castagnoli A; Cuneo A; Castoldi GL
Cancer Genet Cytogenet; 1992 Jul; 61(1):11-3. PubMed ID: 1353407
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome.
Fizzotti M; Chen EY; Link MP; Carroll AJ; Foroni L; Rabbitts TH; Crist WM; Clark SS
Leukemia; 1994 Jul; 8(7):1124-30. PubMed ID: 8035604
[TBL] [Abstract][Full Text] [Related]
19. [Philadelphia-positive ALL with rearrangement of the 1st intron of the BCR gene].
Valiente A; Escudero A; Benítez J
Sangre (Barc); 1991 Dec; 36(6):505-8. PubMed ID: 1812584
[TBL] [Abstract][Full Text] [Related]
20. Philadelphia chromosome- positive myelodysplastic syndrome with single lineage dysplasia.
Kumar A; Tilak V; Arora D; Marisha ; Rahul ; Gautam D; Ali A
Cancer Genet; 2023 Aug; 276-277():12-16. PubMed ID: 37267684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
